These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26485172)

  • 1. Variation in attrition at subnational level: review of the Botswana National HIV/AIDS Treatment (Masa) programme data (2002-2013).
    Farahani M; Price N; El-Halabi S; Mlaudzi N; Keapoletswe K; Lebelonyane R; Fetogang EB; Chebani T; Kebaabetswe P; Masupe T; Gabaake K; Auld A; Nkomazana O; Marlink R
    Trop Med Int Health; 2016 Jan; 21(1):18-27. PubMed ID: 26485172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Health System Inputs on Health Outcome: A Multilevel Longitudinal Analysis of Botswana National Antiretroviral Program (2002-2013).
    Farahani M; Price N; El-Halabi S; Mlaudzi N; Keapoletswe K; Lebelonyane R; Fetogang EB; Chebani T; Kebaabetswe P; Masupe T; Gabaake K; Auld AF; Nkomazana O; Marlink R
    PLoS One; 2016; 11(8):e0160206. PubMed ID: 27490477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Pakam R; Midde M
    Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
    Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
    PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of the Botswana national HIV/AIDS treatment programme from 2002 to 2010: a longitudinal analysis.
    Farahani M; Vable A; Lebelonyane R; Seipone K; Anderson M; Avalos A; Chadborn T; Tilahun H; Roumis D; Moeti T; Musuka G; Busang L; Gaolathe T; Malefho KC; Marlink R
    Lancet Glob Health; 2014 Jan; 2(1):e44-50. PubMed ID: 25104635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competing risk of mortality on loss to follow-up outcome among patients with HIV on ART: a retrospective cohort study from the Zimbabwe national ART programme.
    Matsena Zingoni Z; Chirwa T; Todd J; Musenge E
    BMJ Open; 2020 Oct; 10(10):e036136. PubMed ID: 33028546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
    Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess mortality associated with mental illness in people living with HIV in Cape Town, South Africa: a cohort study using linked electronic health records.
    Haas AD; Ruffieux Y; van den Heuvel LL; Lund C; Boulle A; Euvrard J; Orrell C; Prozesky HW; Tiffin N; Lovero KL; Tlali M; Davies MA; Wainberg ML;
    Lancet Glob Health; 2020 Oct; 8(10):e1326-e1334. PubMed ID: 32971055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Same-day antiretroviral therapy is associated with increased loss to follow-up in South African public health facilities: a prospective cohort study of patients diagnosed with HIV.
    Joseph Davey D; Kehoe K; Serrao C; Prins M; Mkhize N; Hlophe K; Sejake S; Malone T
    J Int AIDS Soc; 2020 Jun; 23(6):e25529. PubMed ID: 32510186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with pre-ART loss-to-follow up in adults in rural KwaZulu-Natal, South Africa: a prospective cohort study.
    Evangeli M; Newell ML; McGrath N
    BMC Public Health; 2016 Apr; 16():358. PubMed ID: 27117271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Survival probability and factors associated with time to loss to follow-up and mortality among patients on antiretroviral treatment in central Kenya.
    Wekesa P; McLigeyo A; Owuor K; Mwangi J; Ngugi E
    BMC Infect Dis; 2022 Jun; 22(1):522. PubMed ID: 35668350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alarming attrition rates among HIV-infected individuals in pre-antiretroviral therapy care in Myanmar, 2011-2014.
    Oo MM; Gupta V; Aung TK; Kyaw NT; Oo HN; Kumar AM
    Glob Health Action; 2016; 9():31280. PubMed ID: 27562473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD4-specific mortality rates among HIV-infected adults with high CD4 counts and no antiretroviral treatment in West Africa.
    Lewden C; Gabillard D; Minga A; Ekouévi DK; Avit D; Konate I; Amani-Bossé C; Messou E; Coffie P; Ouedraogo A; Laurent C; Anglaret X;
    J Acquir Immune Defic Syndr; 2012 Feb; 59(2):213-9. PubMed ID: 22027874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attrition and treatment outcomes among adolescents and youths living with HIV in the Thai National AIDS Program.
    Teeraananchai S; Puthanakit T; Kerr SJ; Chaivooth S; Kiertiburanakul S; Chokephaibulkit K; Bhakeecheep S; Teeraratkul A; Law M; Ruxrungtham K
    J Virus Erad; 2019 Jan; 5(1):33-40. PubMed ID: 30800424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement in mortality and retention among adult HIV-infected patients in the first 12 months of antiretroviral therapy in Dodoma urban district, Tanzania.
    Tweve EN; Kayabu D; Nassari NO; Todd J
    Trop Med Int Health; 2015 Jun; 20(6):791-6. PubMed ID: 25706518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal trends in treatment outcomes for HIV-1 and HIV-2-infected adults enrolled in Côte d'Ivoire's national antiretroviral therapy program.
    Auld AF; Ekra KA; Shiraishi RW; Tuho MZ; Kouakou JS; Mohamed F; Ettiègne-Traoré V; Sabatier J; Essombo J; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    PLoS One; 2014; 9(5):e98183. PubMed ID: 24866468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality and losses to follow-up among adolescents living with HIV in the IeDEA global cohort collaboration.
    Kariminia A; Law M; Davies MA; Vinikoor M; Wools-Kaloustian K; Leroy V; Edmonds A; McGowan C; Vreeman R; Fairlie L; Ayaya S; Yotebieng M; Takassi E; Pinto J; Adedimeji A; Malateste K; Machado DM; Penazzato M; Hazra R; Sohn AH;
    J Int AIDS Soc; 2018 Dec; 21(12):e25215. PubMed ID: 30548817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mortality and Loss to Follow up Before Initiation of Antiretroviral Therapy Among HIV-Infected Children Eligible for HIV Treatment.
    Alvarez-Uria G; Naik PK; Midde M; Pakam R
    Infect Dis Rep; 2014 May; 6(2):5167. PubMed ID: 25002959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of loss to follow-up after engagement in care of HIV-infected children ineligible for antiretroviral therapy in an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Midde M; Pakam R
    Germs; 2014 Mar; 4(1):9-15. PubMed ID: 24639956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.